Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2192-2195

  Cuenca Estrella, Manuel ^a   Gomez Lopez, Alicia ^a   Mellado, Emilia ^a   Monzon, Araceli ^a   Buitrago, Maria J ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ACREMONIUM; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; BASIDIOMYCETES; CANDIDA; MINIMUM INHIBITORY CONCENTRATION; MUCORALES; NONHUMAN; PENICILLIUM; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM; SPAIN;

ACREMONIUM; ANTIFUNGAL AGENTS; ASPERGILLUS; CANDIDA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGI; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MYCOSES; PENICILLIUM; SCEDOSPORIUM; SPAIN;

EID: 66149156191     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01543-08     Document Type: Article

References (22)

1. Antachopoulos, C., J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh. 2008. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrob. Agents Chemother. 52:321-328.
2. Arikan, S., P. Yurdakul, and G. Hascelik. 2003. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob. Agents Chemother. 47:2640-2643. (Pubitemid 36919471)
3. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Monzon, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921. (Pubitemid 43327795)
4. Dannaoui, E., O. Lortholary, D. Raoux, M. E. Bougnoux, G. Galeazzi, C. Lawrence, D. Moissenet, I. Poilane, D. Hoinard, and F. Dromer. 2008. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob. Agents Chemother. 52:778-781.
5. Guinea, J., T. Pelaez, L. Alcala, M. J. Ruiz-Serrano, and E. Bouza. 2005. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob. Agents Chemother. 49:3495-3497.
6. Laverdiere, M., A. C. Labbe, C. Restieri, C. Rotstein, D. Heyland, S. Madger, and T. Stewart. 2007. Susceptibility patterns of Candida species recovered from Canadian intensive care units. J. Crit. Care 22:245-250.
7. Odds, F. C., M. Motyl, R. Andrade, J. Bille, E. Canton, M. Cuenca-Estrella, A. Davidson, C. Durussel, D. Ellis, E. Foraker, A. W. Fothergill, M. A. Ghannoum, R. A. Giacobbe, M. Gobernado, R. Handke, M. Laverdiere, W. Lee-Yang, W. G. Merz, L. Ostrosky-Zeichner, J. Peman, S. Perea, J. R. Perfect, M. A. Pfaller, L. Proia, J. H. Rex, M. G. Rinaldi, J. L. Rodriguez-Tudela, W. A. Schell, C. Shields, D. A. Sutton, P. E. Verweij, and D. W. Warnock. 2004. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42:3475-3482. (Pubitemid 39045669)
8. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
9. Panagopoulou, P., J. Filioti, E. Farmaki, A. Maloukou, and E. Roilides. 2007. Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs. Infect. Control Hosp. Epidemiol. 28:60-67. (Pubitemid 46219227)
10. Perlin, D. S. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resistance Updates 10:121-130. (Pubitemid 47031054)
11. Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
12. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2006. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J. Clin. Microbiol. 44:3533-3538.
13. Pfaller, M. A., D. J. Diekema, D. L. Gibbs, V. A. Newell, K. P. Ng, A. Colombo, J. Finquelievich, R. Barnes, and J. Wadula. 2008. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46:842-849.
14. Pfaller, M. A., D. J. Diekema, L. Ostrosky-Zeichner, J. H. Rex, B. D. Alexander, D. Andes, S. D. Brown, V. Chaturvedi, M. A. Ghannoum, C. C. Knapp, D. J. Sheehan, and T. J. Walsh. 2008. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J. Clin. Microbiol. 46:2620-2629.
15. Rautemaa, R., M. Richardson, M. A. Pfaller, J. Perheentupa, and H. Saxen. 2008. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. Diagn. Microbiol. Infect. Dis. 62:182-185.
16. Richards, T. S., B. G. Oliver, and T. C. White. 2008. Micafungin activity against Candida albicans with diverse azole resistance phenotypes. J. Antimicrob. Chemother. 62:349-355.
17. Rodriguez-Tudela, J. L., M. C. Arendrup, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. W. Denning, J. P. Donnelly, F. Dromer, W. Fegeler, C. Lass-Florl, C. Moore, M. Richardson, P. Sandven, A. Velegraki, and P. Verweij. 2008. EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405.
18. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Danaoui, D. Denning, W. Fegeler, P. Gaustad, C. Lass-Florl, C. Moore, M. Richardson, A. Schmalreck, J. A. Velegraki, and P. Verweij. 2008. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds-subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST). Clin. Microbiol. Infect. 14:982-984.
19. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. Denning, W. Fegeler, P. Gaustad, N. Klimko, C. Lass-Florl, C. Moore, M. Richardson, A. Schmalreck, J. Stenderup, A. Velegraki, and P. Verweij. 2008. EUCAST Technical Note on fluconazole. Clin. Microbiol. Infect. 14:193-195.
20. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. Denning, W. Fegeler, P. Gaustad, C. Lass-Flori, C. Moore, M. Richardson, A. Schmalreck, J. A. Velegraki, and P. Verweij. 2008. EUCAST Technical Note on voriconazole - subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST). Clin. Microbiol. Infect. 14:985-987.
21. Takakura, S., N. Fujihara, T. Saito, T. Kudo, Y. Iinuma, and S. Ichiyama. 2004. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J. Antimicrob. Chemother. 53:283-289.
22. Zeng, J., K. Kamei, Y. Zheng, and K. Nishimura. 2004. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents. Nippon Ishinkin Gakkai Zasshi 45:101-104.